Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Pentamidine is an antifungal agent used to treat Pneumocystis pneumonia in patients infected with HIV. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
- Mechanism
- Curator reviewed
The mode of action of pentamidine is not fully understood. It is thought that the drug interferes with nuclear metabolism producing inhibition of the synthesis of DNA, RNA, phospholipids, and proteins.
- Primary indication
- For the treatment of pneumonia due to Pneumocystis carinii.Curator reviewed · 5 structured indications
- Formula / weight
- C19H24N4O2 · 340.4195 g/mol (avg)
- First approval
- Canada, 2000 · United States, 1994
- Code names
- MB 800 · RP 2512
- Brand names
- Nebupent
- Pentam
Resolves to
Clinical / RWD
Structure
InChIKey
XDRYMKDFEDOLFX-UHFFFAOYSA-NSMILESNC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1Transporters
What you can answer from here — as of September 23, 2026
14Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Pentamidine, and which of those have an active Phase 3 trial?